Target intelligence / Profile preview

Fungal alpha-1,3-glucan and alpha-1,6-glucan

Molecular classification
Polysaccharide, Carbohydrate, Fungal cell wall component
01

Overview

Fungal alpha-1,3-glucan and alpha-1,6-glucan are essential polysaccharide components of the cell walls of various pathogenic fungi, including Aspergillus fumigatus, Histoplasma capsulatum, and Cryptococcus neoformans (Beauvais et al., 2001, Journal of Bacteriology). Alpha-1,3-glucan, in particular, is a critical virulence factor that provides structural support and facilitates immune evasion by masking beta-glucans from detection by host pattern recognition receptors like Dectin-1 (Rappleye et al., 2007, Science). Alpha-1,6-glucan linkages are also found in fungal cell wall structures, often as part of more complex glycan networks that contribute to the organism's environmental resilience and adherence (Fujiwara et al., 2022, Journal of Fungi). These alpha-glucans are synthesized by fungal-specific enzymes, such as alpha-1,3-glucan synthase (AGS), which are absent in mammalian hosts, making them promising targets for the development of highly selective antifungal agents (Marion et al., 2006, Molecular Microbiology). Although no drugs targeting these specific glucans are currently FDA-approved, they are being actively investigated as targets for small-molecule inhibitors, monoclonal antibodies, and carbohydrate-based vaccines (Stayer et al., 2020, Frontiers in Cellular and Infection Microbiology). Successful targeting of these molecules could lead to weakened fungal cell walls and enhanced host immune clearance, providing a novel approach to treating life-threatening invasive fungal infections.

Other names
Alpha-glucan1,3-alpha-D-glucan1,6-alpha-D-glucanPseudonigeranNigeranFungal cell wall alpha-glucan
02

Mechanism of action

Inhibition of fungal cell wall biosynthesis through the targeting of alpha-glucan synthase enzymes, or direct binding and neutralization of cell wall glucans by monoclonal antibodies to promote immune-mediated clearance.

03

Biological functions

Cell wall structural integrityImmune evasionVirulence factorAdhesion
04

Disease associations

Invasive aspergillosisHistoplasmosisBlastomycosisParacoccidioidomycosisCryptococcosisInfection
05

Safety considerations

Potential disruption of the host's commensal fungal microbiomeLimited efficacy against fungal species lacking significant alpha-glucan layersPotential cross-reactivity with host alpha-glycans (though rare)
06

Interacting drugs

Experimental alpha-1,3-glucan synthase inhibitors

1 more in the full profile.

07

Biomarkers

Serum alpha-1,3-glucan levelsAlpha-1,3-glucan synthase (AGS) expression levels

Beyond the preview

Go deeper on Fungal alpha-1,3-glucan and alpha-1,6-glucan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fungal alpha-1,3-glucan and alpha-1,6-glucan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call